Neon Therapeutics, Inc. Made Headway

Thu 16 Jan 20 at 05:30 PM
Neon Therapeutics, Inc. Made Headway

Neon Therapeutics, Inc. (NTGN:NASDAQ) jumped higher at $1.7, representing a gain of 38.2%. On Wed 15 Jan 20, NTGN:NASDAQ hit a New 2-Week Intraday High of $1.29. The stock appeared on our News Catalysts scanner on Thu 16 Jan 20 at 08:29 AM in the 'ACQUISITION' category. From Tue 24 Dec 19, the stock recorded 42.86% Up Days and 26.67% Green Days

The share price of the company has been moving sideways in recent weeks.

About Neon Therapeutics, Inc. (NTGN:NASDAQ)

Neon Therapeutics Inc is a clinical-stage biopharmaceutical company. It is focused in the field of neoantigen-targeted therapies, dedicated to transforming the treatment of cancer by directing the immune system towards neoantigens. The company's pipeline products are NEO-PV-01, NEO-PTC-01, and NEO-SV-01.